Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00504881
Status:
COMPLETED
Last Update Posted:
2018-04-03
First Post:
2007-07-19
Brief Title:
Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Sponsor:
UCB Pharma SA
Organization:
UCB Pharma
Study Overview
Official Title:
An International Randomized Double-blind Parallel-group Placebo-controlled Flexible Dose Study Evaluation of the Safety and Efficacy of Brivaracetam in Subjects 16 to 70 Years Old Suffering From Localization-related or Generalized Epilepsy
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the safety and efficacy of Brivaracetam at flexible dose with Placebo in subjects suffering from Epilepsy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006-006346-34 | EUDRACT_NUMBER | None | None |